Indication
Primary Open-Angle Glaucoma
3 clinical trials
5 products
Product
QLS-111Clinical trial
A Randomized, Multi-site, Double-masked Study Evaluating the Safety and Tolerability of QLS-111 vs Vehicle in Primary Open-angle Glaucoma or Ocular Hypertension PatientsStatus: Recruiting, Estimated PCD: 2024-09-05
Product
QLS-111 ophthalmic solutionClinical trial
A Phase 1/2a Assessment of WB007 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular HypertensionStatus: Completed, Estimated PCD: 2021-01-31
Product
WB007Product
TimololClinical trial
The Effect of Lumify™ (Brimonidine Tartrate Ophthalmic Solution 0.025%) on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients Using Brimonidine 0.2%, 0.15%, or 0.1%Status: Not yet recruiting, Estimated PCD: 2030-06-01